4//SEC Filing
VENROCK ASSOCIATES II LP 4
Accession 0000937889-13-000001
CIK 0001446847other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 7:46 PM ET
Size
14.4 KB
Accession
0000937889-13-000001
Insider Transaction Report
Form 4
VR Management LLC
10% Owner
Transactions
- Other
Class B Common Stock
2013-03-15−920,832→ 2,762,497 total - Other
Class B Common Stock
2013-03-15−639,901→ 1,919,704 total
Holdings
- 40,000
Class B Common Stock
- 48,387
Class B Common Stock
- 2,442
Class A Common Stock
VENROCK ENTERPRENEURS FUND LP
10% Owner
Transactions
- Other
Class B Common Stock
2013-03-15−920,832→ 2,762,497 total - Other
Class B Common Stock
2013-03-15−639,901→ 1,919,704 total
Holdings
- 48,387
Class B Common Stock
- 40,000
Class B Common Stock
- 2,442
Class A Common Stock
VENROCK ASSOCIATES II LP
10% Owner
Transactions
- Other
Class B Common Stock
2013-03-15−639,901→ 1,919,704 total - Other
Class B Common Stock
2013-03-15−920,832→ 2,762,497 total
Holdings
- 48,387
Class B Common Stock
- 40,000
Class B Common Stock
- 2,442
Class A Common Stock
VENROCK ASSOCIATES
10% Owner
Transactions
- Other
Class B Common Stock
2013-03-15−920,832→ 2,762,497 total - Other
Class B Common Stock
2013-03-15−639,901→ 1,919,704 total
Holdings
- 48,387
Class B Common Stock
- 40,000
Class B Common Stock
- 2,442
Class A Common Stock
Footnotes (6)
- [F1]Each share of Class B Common Stock is convertible at any time at the option of the holder thereof into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon (i) any transfer, whether or not for value, (subject to certain exceptions); (ii) in the event of death of the reporting person; or (iii) the earliest of the following (A) the later of (1) the first date on which the number of shares of Class B Common Stock then outstanding represents less than 25% of the number of shares of Class B Common Stock outstanding at the closing of the Issuer's initial public offering, or (2) December 31, 2018, (B) December 31, 2038, or (C) the date agreed to in writing by the holders of at least a majority of then outstanding shares of Class B common stock.
- [F2]On March 15, 2013, Venrock Associates distributed an aggregate of 639,901 shares of the Class A Common Stock of the issuer to its partners pro rata based on their respective interests in Venrock Associates. After the distribution, Venrock Associates held an aggregate of 1,919,704 shares of Class B Common Stock of the issuer.
- [F3]On March 15, 2013, Venrock Associates II, L.P. distributed an aggregate of 920,832 shares of the Class A Common Stock of the issuer to its partners pro rata based on their respective interests in Venrock Associates II, L.P. After the distribution, Venrock Associates II, L.P. held an aggregate of 2,762,497 shares of Class B Common Stock of the issuer.
- [F4]Consists of 48,387 shares of Class B Common Stock of the issuer held by Venrock Entrepreneurs Fund, L.P.
- [F5]Consists of 40,000 shares of Class B Common Stock of the issuer held by VR Managment, LLC.
- [F6]Consists of 2,442 shares of Class A Common Stock of the issuer held by VR Managment, LLC.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001239243
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 7:46 PM ET
- Size
- 14.4 KB